In this respect, an intriguing perspective is the therapeutic potential of inhibiting the PERK/p-eIF2α pathway to enhance protein synthesis and promote brain remodeling, thus improving long-term functional recovery after stroke. This evidence concerns the gene EIF2AK3 and Stroke.